Clinical Significance of Vascular Endothelial Growth Factors (VEGF)-C and -D in Resected Non-Small Cell Lung Cancer
Cancer Research and Treatment. 2008;40(3):133 
4 Vascular endothelial growth factor (VEGF) is an autocrine survival factor in non-small cell lung cancer
Lung Cancer. 2012;75:S2
Combined Inhibition of Vascular Endothelial Growth Factor and Epidermal Growth Factor Signaling in Non–Small-Cell Lung Cancer Therapy
Clinical Lung Cancer. 2009;10:S17-S23
Vascular endothelial growth factor expression and angiogenesis in non-small cell lung carcinomas
Lung Cancer. 1995;13(2):194
Prognostic and predictive value of vascular endothelial growth factor (VEGF) in patients with non small cell lung cancer (NSCLC)
European Journal of Cancer. 2002;38:S77-S78
Optimizing the Dose and Schedule of Anti–Vascular Endothelial Growth Factor Antibodies in Non–Small-Cell Lung Cancer
Clinical Lung Cancer. 2008;9:S51-S56
Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors in Non–Small-Cell Lung Cancer
Clinical Lung Cancer. 2010;11(5):311-319
Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer
Lung Cancer. 1996;15(1):143-144
The prognostic significance of intra-tumoural vascular invasion in surgically resected non-small cell lung cancer
Lung Cancer. 2010;67:S38
Prognostic factors and long-term survival of non-resected cases with non-small cell lung cancer
Lung Cancer. 1996;16(1):114